Loxo Archives - AdvocateHealthyu

Loxo Oncology Announces Initiation of Phase 1/2 Clinical Trial for Highly Selective, Non-Covalent BTK Inhibitor, LOXO-305

STAMFORD, Conn., Dec. 21, 2018 (GLOBE NEWSWIRE) — Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company…

Minced meat Meat spoils quickly and is a good breeding ground for germs. How quickly…

After the fire of Notre-Dame in mid-April, environmental activists accuse the Paris authorities to have…

The girl comes with a age of unusual complaint, in the University hospital in Jeddah,…

Three drug companies will pay a total of nearly $70 million to California to settle…

New warnings about an increased risk of thrombosis and of death among ulcerative colitis patients…

Opioid users tend to be alone and incapacitated during an overdose. Purdue University researchers are…

The best workouts are all about efficiency. Condense a class into 30 minutes? Yes please.…

Gillian Wright, 59, who’s played Jean Slater on the BBC’s EastEnders since 2004, has been…

Alcohol consumption is a major cause of chronic liver disease in the United States, and…